1. Home
  2. MATX vs GKOS Comparison

MATX vs GKOS Comparison

Compare MATX & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matson Inc.

MATX

Matson Inc.

HOLD

Current Price

$183.82

Market Cap

5.4B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$142.58

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATX
GKOS
Founded
1882
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
MATX
GKOS
Price
$183.82
$142.58
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$163.33
$126.92
AVG Volume (30 Days)
196.4K
707.8K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
0.83%
N/A
EPS Growth
N/A
N/A
EPS
1.85
N/A
Revenue
$3,344,500,000.00
$507,442,000.00
Revenue This Year
$4.65
$23.32
Revenue Next Year
$4.31
$27.43
P/E Ratio
$97.04
N/A
Revenue Growth
N/A
32.33
52 Week Low
$86.97
$73.16
52 Week High
$189.99
$146.75

Technical Indicators

Market Signals
Indicator
MATX
GKOS
Relative Strength Index (RSI) 60.46 67.95
Support Level $157.33 $80.14
Resistance Level $189.99 $146.75
Average True Range (ATR) 6.57 6.16
MACD -0.04 0.55
Stochastic Oscillator 79.20 84.68

Price Performance

Historical Comparison
MATX
GKOS

About MATX Matson Inc.

Matson Inc is engaged in providing ocean transportation and logistics services. The company has two reportable business segments: Ocean Transportation and Logistics. The Ocean Transportation segment provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific. The Logistics segment offers long-haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: